DouglasWMapelMD

PubMed

• Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
  Melissa H Roberts, Kieran J Rothnie, Wendy Y Cheng, Philippe Thompson-Leduc, Shiyuan Zhang, Alexandrosz Czira, David Slade, Alexandra Greatsinger, Adina Zhang, Douglas...> ;Respiratory Medicine. 2024 May 1
• Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
  Melissa H Roberts, Mei Sheng Duh, Kieran J Rothnie, Shiyuan Zhang, Alexandrosz Czira, David Slade, Wendy Y Cheng, Philippe Thompson-Leduc, Alexandra Greatsinger, Adina...> ;Respiratory Medicine. 2024 May 1
• National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
  Melissa H Roberts, Qisu Zhang, Orsolya Lunacsek, Shannon Grabich, Joris van Stiphout, Brian L Meadors, Norbert Feigler, Michael F Pollack, David M Mannino, Douglas W M...> ;Chest. 2023 Nov 30
• 8 citations
  Frailty Among Older Individuals with and without COPD: A Cohort Study of Prevalence and Association with Adverse Outcomes.
  Melissa H Roberts, Douglas W Mapel, Nikhil Ganvir, Melanie A Dodd> ;International Journal of Chronic Obstructive Pulmonary Disease. 2022 Jan 1
• 2 citations
  Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease
  Douglas W. Mapel, Melissa H. Roberts, Susan R. Sama, Priyanka Bobbili, Wendy Y. Cheng, Mei Sheng Duh, Catherine Nguyen, Philippe Thompson-Leduc, Melissa K. Van Dyke, K...> ;International Journal of Chronic Obstructive Pulmonary Disease. 2021 Jun 9
• 2 citations
  Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalizat...
  Melissa H. Roberts, Douglas W. Mapel, Hans Petersen> ;Drugs - Real World Outcomes. 2020 Mar 1
• Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease.
  Douglas W. Mapel, Melissa H. Roberts, Jill Davis> ;Journal of Comparative Effectiveness Research. 2020 Jan 27
• 14 citations
  Claims-based risk model for first severe COPD exacerbation
  Richard H. Stanford, Arpita Nag, Douglas W. Mapel, Todd A. Lee, Richard Rosiello, Michael Schatz, Francis Vekeman, Marjolaine Gauthier-Loiselle, J F Philip Merrigan, M...> ;The American Journal of Managed Care. 2018 Feb 1
• 12 citations
  Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
  Christopher M. Blanchette, Joshua M Noone, Glenda Stone, E Zacherle, RP Patel, Reuben Howden, Douglas W. Mapel> ;Medical Sciences. 2017 Sep 23
• 12 citations
  A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly...
  Douglas W. Mapel, François Laliberté, Melissa H. Roberts, Susan R. Sama, Devi Sundaresan, Dominic Pilon, Patrick Lefebvre, Mei Sheng Duh, Jeetvan Patel> ;International Journal of Chronic Obstructive Pulmonary Disease. 2017 Jun 21
• Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.
  Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ> ;N Engl J Med. 2016 May 12
• 27 citations
  A retrospective analysis to identify predictors of COPD-related rehospitalization
  Melissa H. Roberts, Emmanuelle Clerisme-Beaty, Chris M. Kozma, Andrew Paris, Terra Slaton, Douglas W. Mapel> ;BMC Pulmonary Medicine. 2016 Apr 30
• 16 citations
  Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
  Richard H. Stanford, Arpita Nag, Douglas W. Mapel, Todd A. Lee, Richard Rosiello, Francis Vekeman, Marjolaine Gauthier-Loiselle, Mei Sheng Duh, J F Philip Merrigan, Mi...> ;Annals of the American Thoracic Society. 2016 Jul 7
• Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies
  Melissa H. Roberts, Matthew E. Borrego, A.A. Kharat, Patricia Marshik, Douglas W. Mapel> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2016 Feb 3
• 18 citations
  Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
  Douglas W. Mapel, Anand A. Dalal, Phaedra T. Johnson, Laura Becker, Alyssa Goolsby Hunter> ;International Journal of Chronic Obstructive Pulmonary Disease. 2015 Jul 29
• 24 citations
  A clinical study of COPD severity assessment by primary care physicians and their patients compared with spirometry.
  Douglas W. Mapel, Anand A. Dalal, Phaedra T. Johnson, Laura Becker, Alyssa Goolsby Hunter> ;The American Journal of Medicine. 2015 Jun 1
• 4 citations
  Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods
  Melissa H. Roberts, Douglas W. Mapel, Matthew E. Borrego, Dennis W. Raisch, Larry Georgopoulos, David N. van der Goes> ;Drugs - Real World Outcomes. 2015 Apr 28
• 23 citations
  Clinical factors, including All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation
  Melissa H. Roberts, Douglas W. Mapel, Ann Von Worley, Janice Beene> ;Drugs in Context. 2015 Mar 18
• 12 citations
  The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease
  Melissa H. Roberts, Douglas W. Mapel, Heather Thomson> ;Clinicoeconomics and Outcomes Research. 2015 Mar 26
• 36 citations
  The epidemiology and treatment of anal fissures in a population-based cohort
  Douglas W. Mapel, Michael Schum, Ann Von Worley> ;BMC Gastroenterology. 2014 Jul 16
• 9 citations
  Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectivene...
  Douglas W. Mapel, Melissa H. Roberts> ;Drugs. 2014 May 6
• 14 citations
  Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease.
  Douglas W. Mapel> ;Current Opinion in Pulmonary Medicine. 2014 Mar 1
• 12 citations
  Functional disorders of the gastrointestinal tract: Cost effectiveness review.
  Douglas W. Mapel> ;Best Practice & Research. Clinical Gastroenterology. 2013 Dec 1
• 9 citations
  Development of a Modified BODE Index as a Mortality Risk Measure Among Older Adults With and Without Chronic Obstructive Pulmonary Disease
  Melissa H. Roberts, Douglas W. Mapel, Shannon Bruse, Hans Petersen, Toru Nyunoya> ;American Journal of Epidemiology. 2013 Oct 1
• 224 citations
  Cardiovascular Comorbidity in COPD: Systematic Literature Review
  Hana Müllerová, Alvar Agusti, Sebhat Erqou, Douglas W. Mapel> ;Chest. 2013 Oct 1
• Join now to see all